About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
237 genotypes with 242 annotations displayed of selected term and subterms
Searched Term: increased acute inflammation
Allelic Composition
(Genetic Background)		 Annotated Term Reference
Adamts18tm1.1Wzha/Adamts18tm1.1Wzha
(involves: 129 * C57BL/6) 		increased acute inflammation J:258487
Adora2btm1Till/Adora2btm1Till
(B6.129P2-Adora2btm1Till) 		increased susceptibility to type I hypersensitivity reaction J:125297
Agp1NZB/Agp1NZB
(involves: NZB * NZW) 		increased susceptibility to type III hypersensitivity reaction J:6920
Agp1NZB/Agp1NZW
(involves: NZB * NZW) 		increased susceptibility to type III hypersensitivity reaction J:6920
Agp2NZB/Agp2NZW
(involves: NZB * NZW) 		increased susceptibility to type III hypersensitivity reaction J:6920
Agp2NZW/Agp2NZW
(involves: NZB * NZW) 		increased susceptibility to type III hypersensitivity reaction J:6920
Aknatm1Mak/Aknatm1Mak
(B6.129P2-Aknatm1Mak) 		increased acute inflammation J:233952
Arhgap25tm1a(KOMP)Wtsi/Arhgap25tm1a(KOMP)Wtsi
(involves: C57BL/6N) 		increased acute inflammation J:240521
Arrb2tm1Rjl/Arrb2tm1Rjl
(involves: 129X1/SvJ * C57BL/6) 		increased acute inflammation J:112607
increased susceptibility to endotoxin shock J:112607
Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu/Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu
(B6.FVB-Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu) 		increased susceptibility to endotoxin shock J:208213
Atf2tm1Glm/Atf2tm1Glm
(C.Cg-Atf2tm1Glm) 		increased susceptibility to endotoxin shock J:67176
Bcrtm1Hkp/Bcrtm1Hkp
(involves: 129S2/SvPas) 		increased susceptibility to endotoxin shock J:23804
C1qtnf4em1Smoc/C1qtnf4em1Smoc
(C57BL/6J-C1qtnf4em1Smoc/Smoc) 		increased susceptibility to endotoxin shock J:302282
C1qtnf6tm1Yiw/C1qtnf6tm1Yiw
(B6.129P2-C1qtnf6tm1Yiw) 		increased susceptibility to type III hypersensitivity reaction J:227217
C3ar1tm1Raw/C3ar1tm1Raw
(involves: 129X1/SvJ * C57BL/6) 		increased susceptibility to endotoxin shock J:68807
C3ar1tm1Raw/C3ar1tm1Raw
(B6.129X1(B6)-C3ar1tm1Raw) 		increased susceptibility to type I hypersensitivity reaction J:80071
C3ar1tm1Raw/C3ar1tm1Raw
Cpn1tm1Raw/Cpn1tm1Raw
(B6.129-C3ar1tm1Raw Cpn1tm1Raw) 		increased acute inflammation J:148315
Casp12tm1Dwni/Casp12tm1Dwni
(involves: 129S1/SvImJ * C57BL/6) 		increased susceptibility to endotoxin shock J:144912
Ccr1tm1Cge/Ccr1tm1Cge
(involves: 129S4/SvJae) 		increased susceptibility to type IV hypersensitivity reaction J:115119
Ccr5tm1Brv/Ccr5tm1Brv
(either: (involves: 129S1/Sv * ICR) or (involves: 129S1/Sv * 129X1/SvJ * ICR)) 		increased susceptibility to type IV hypersensitivity reaction J:46941
Cd28tm1Jmg/Cd28tm1Jmg
(B6.129X1-Cd28tm1Jmg) 		increased susceptibility to type I hypersensitivity reaction J:149888
Cd28tm1Mak/Cd28tm1Mak
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to type I hypersensitivity reaction J:149888
Cd44tm1Hbg/Cd44tm1Hbg
(involves: 129S1/Sv * 129X1/SvJ) 		increased acute inflammation J:131974
Cd96tm1.1Mjs/Cd96tm1.1Mjs
(B6.129P2(Cg)-Cd96tm1.1Mjs) 		increased susceptibility to endotoxin shock J:209990
Cd276tm1Lpc/Cd276tm1Lpc
(B6.129-Cd276tm1Lpc) 		increased susceptibility to type I hypersensitivity reaction J:237700
Cd300lftm1Toki/Cd300lftm1Toki
(Not Specified) 		increased susceptibility to type I hypersensitivity reaction J:190979
Cfhtm1Mbo/Cfhtm1Mbo
(involves: 129/Sv * C57BL/6) 		increased susceptibility to type III hypersensitivity reaction J:78193
Chuktm1Mpa/Chuktm1Mpa
Ikbkbtm2Cgn/Ikbkbtm2Cgn
Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N) 		increased susceptibility to endotoxin shock J:137861
Cishtm1.1Cdon/Cishtm1.1Cdon
Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased susceptibility to type I hypersensitivity reaction J:204829
Cishtm1.2Cdon/Cishtm1.2Cdon
(B6.129S6(Cg)-Cishtm1.2Cdon) 		increased susceptibility to type I hypersensitivity reaction J:204829
Cmklr1tm1Dgen/Cmklr1tm1Dgen
(B6.Cg-Cmklr1tm1Dgen) 		increased susceptibility to endotoxin shock J:157190
Coro1atm1Achn/Coro1atm1Achn
Coro1btm1.1Nfoe/Coro1btm1.1Nfoe
(involves: 129X1/SvJ * C57BL/6N) 		increased susceptibility to type I hypersensitivity reaction J:177785
Cpn1tm1Raw/Cpn1tm1Raw
(B6.129S1-Cpn1tm1Raw) 		increased acute inflammation J:148315
Csktm1Tara/Csktm2Tara
Elanetm1(cre)Roes/Elane+
(involves: 129P2/OlaHsd * CB20 * C57BL/6) 		increased acute inflammation J:89716
Ctla4tm1All/Ctla4tm1All
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * NOD) 		increased acute inflammation J:109887
Ctla4tm1All/Ctla4tm1All
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * NOD * SJL) 		increased acute inflammation J:109887
Cybbtm1Din/Cybbtm1Din
(B6.129S-Cybbtm1Din) 		increased acute inflammation J:110181
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to endotoxin shock J:118833
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas * various) 		increased susceptibility to type I hypersensitivity reaction J:125919
Dusp1tm1Lex/Dusp1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased susceptibility to endotoxin shock J:126383
Dusp10tm1Flv/Dusp10tm1Flv
(involves: 129S6/SvEvTac) 		increased susceptibility to type I hypersensitivity reaction J:92104
Dusp11Gt(BB0198)Wtsi/Dusp11Gt(BB0198)Wtsi
(B6.129P2-Dusp11Gt(BB0198)Wtsi) 		increased susceptibility to endotoxin shock J:301503
Eif2ak2tm1Cwe/Eif2ak2tm1Cwe
(involves: 129S/SvEv * C57BL/6) 		increased susceptibility to type IV hypersensitivity reaction J:66112
Elavl1tm1.1Dkon/Elavl1tm1.1Dkon
Lyz2tm1(cre)Ifo/Lyz2+
(B6.129P2-Elavl1tm1.1Dkon Lyz2tm1(cre)Ifo) 		increased susceptibility to endotoxin shock J:184388
Elavl1tm1.1Dkon/Elavl1tm1.1Dkon
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to endotoxin shock J:184388
Enpp3tm1Ktak/Enpp3tm1Ktak
(either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c * C57BL/6)) 		increased susceptibility to type I hypersensitivity reaction J:223825
Epcamtm1.1Mcu/Epcamtm1.1Mcu
Tg(CD207-cre)1Dhka/0
(involves: 129 * C57BL/6 * C57BL/6J * SJL/J) 		increased susceptibility to type IV hypersensitivity reaction J:182665
Exph5tm1Tiz/Exph5tm1Tiz
(B6NJcl.Cg-Exph5tm1Tiz/Tiz) 		increased susceptibility to type I hypersensitivity reaction J:313415
F2rtm1Ajc/F2rtm1Ajc
F2rl1tm1Cgh/F2rl1tm1Cgh
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to endotoxin shock J:132733
F11rtm1.1Dej/F11rtm1.1Dej
(Not Specified) 		increased susceptibility to type IV hypersensitivity reaction J:92592
Faslpr/Faslpr
(involves: C3H * MRL/Mp) 		increased susceptibility to type III hypersensitivity reaction J:34296
Fbn1Tsk/Fbn1+
(B6.Cg-Fbn1Tsk) 		increased susceptibility to type IV hypersensitivity reaction J:7185
Fcer1atm1Knt/Fcer1atm1Knt
(involves: 129 * BALB/c) 		increased susceptibility to type I hypersensitivity reaction J:78659
Fcer1atm1Knt/Fcer1atm1Knt
Fcer2atm1Max/Fcer2atm1Max
Fcgr1tm1Jsv/Fcgr1tm1Jsv
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Fcgr3tm1Jsv/Fcgr3tm1Jsv
(B6.Cg-Fcgr2btm1Ttk Fcgr3tm1Jsv Fcer1atm1Knt Fcgr1tm1Jsv Fcer2atm1Max) 		increased susceptibility to type I hypersensitivity reaction J:144620
Fcer2atm1Max/Fcer2atm1Max
(involves: C57BL/6) 		increased susceptibility to type I hypersensitivity reaction J:57738
Fcer2atm1Max/Fcer2atm1Max
Ighg1tm1.1Pyu/Ighg1+
(involves: 129 * BALB/cJ * C57BL/6 * C57BL/6J) 		increased susceptibility to type I hypersensitivity reaction J:198154
Fcer2atm1Max/Fcer2atm1Max
Ighg1tm1.1Pyu/Ighg1tm1.1Pyu
(involves: 129 * BALB/cJ * C57BL/6 * C57BL/6J) 		increased susceptibility to type I hypersensitivity reaction J:198154
Fcgr2btm1Ttk/Fcgr2btm1Ttk
(involves: 129S4/SvJae) 		increased susceptibility to type I hypersensitivity reaction J:31133
Festm2Pag/Festm2Pag
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		increased susceptibility to endotoxin shock J:98590
Flgtm1Amag/Flgtm1Amag
(involves: 129S6/SvEvTac * BALB/c * C57BL/6NTac) 		increased susceptibility to type IV hypersensitivity reaction J:198332
Fostm3.1Wag/Fostm3.1Wag
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		increased susceptibility to endotoxin shock J:175064
Fostm4.1Wag/Fostm4.1Wag
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		increased susceptibility to endotoxin shock J:175064
Fostm5.1Wag/Fostm5.1Wag
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		increased susceptibility to endotoxin shock J:175064
Fostm6.1Wag/Fostm6.1Wag
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		increased susceptibility to endotoxin shock J:175064
Fostm7Wag/Fostm7Wag
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to endotoxin shock J:175064
Foxp3tm1(CD2/CD52)Shori/Foxp3tm1(CD2/CD52)Shori
(involves: C57BL/6) 		increased susceptibility to type IV hypersensitivity reaction J:171378
Fpr2tm1Rjf/Fpr2tm1Rjf
(involves: 129S/SvEv * C57BL/6) 		increased acute inflammation J:159658
Fyntm1Rmp/Fyntm1Rmp
(B6.129S2-Fyntm1Rmp) 		increased susceptibility to type I hypersensitivity reaction J:114287
Gfi1tm1Tmo/Gfi1tm1Tmo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to endotoxin shock J:75143
Gna12tm1Citb/Gna12tm1Citb
Gna13tm2.1Soff/Gna13tm2.1Soff
Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		increased susceptibility to type IV hypersensitivity reaction J:149560
Gpa33tm1Jkhh/Gpa33tm1Jkhh
(B6.129-Gpa33tm1Jkhh) 		increased susceptibility to type IV hypersensitivity reaction J:224768
Gpr34tm1.1Shbg/Gpr34tm1.1Shbg
(B6.Cg-Gpr34tm1.1Shbg) 		increased susceptibility to type IV hypersensitivity reaction J:168120
Gpr108tm1.1Brs/Gpr108tm1.1Brs
(involves: 129S6/SvEvTac) 		increased susceptibility to endotoxin shock J:266821
Gt(ROSA)26Sortm1.1(DUX4*)Plj/Gt(ROSA)26Sor+
Tg(ACTA1-cre/Esr1*)2Kesr/0
(involves: C3H * C57BL/6) 		increased acute inflammation J:256652
H2q/?
Ncf1m1J/Ncf1m1J
(B6.Cg-Ncf1m1J H2q) 		increased susceptibility to type IV hypersensitivity reaction J:92437
Hmgb1tm1.1Ttg/Hmgb1tm1.1Ttg
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd) 		increased susceptibility to endotoxin shock J:205499
Hnrnpdtm1Rjsc/Hnrnpdtm1Rjsc
(involves: 129S6/SvEvTac * C57BL/6J) 		increased susceptibility to endotoxin shock J:116112
Hpgdstm1Urad/Hpgdstm1Urad
(B6.129-Hpgdstm1Urad) 		increased acute inflammation J:107651
increased susceptibility to type I hypersensitivity reaction J:197334
Hspa12atm1.1Zdi/Hspa12atm1.1Zdi
(involves: 129 * C57BL/6) 		increased susceptibility to endotoxin shock J:302787
Ifnar2tm1Pjh/Ifnar2tm1Pjh
Il6sttm1Ern/Il6sttm1Ern
(involves: 129S1/Sv) 		increased susceptibility to endotoxin shock J:168781
Ifngtm1Ts/Ifngtm1Ts
(B6.129S7-Ifngtm1Ts/J) 		increased susceptibility to type IV hypersensitivity reaction J:118730
Ighg1tm1.1Pyu/Ighg1+
(B6.C(Cg)-Ighg1tm1.1Pyu) 		increased susceptibility to type I hypersensitivity reaction J:198154
Ighg1tm1.1Pyu/Ighg1tm1.1Pyu
(B6.C(Cg)-Ighg1tm1.1Pyu) 		increased susceptibility to type I hypersensitivity reaction J:198154
Ikbkgtm1.1Mpa/Ikbkgtm1.1Mpa
Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N) 		increased susceptibility to endotoxin shock J:137861
Il1rntm1Dih/Il1rn+
(involves: 129S/SvEv * C57BL/6J) 		increased susceptibility to endotoxin shock J:36387
Il1rntm1Dih/Il1rntm1Dih
(involves: 129S/SvEv * C57BL/6J) 		increased acute inflammation J:61600, J:88605
increased susceptibility to endotoxin shock J:36387
Il4ratm2Tch/Il4ratm2Tch
(C.129X1-Il4ratm2Tch) 		increased susceptibility to type I hypersensitivity reaction J:152376
Il4ratm3.1Tch/Il4ratm3.1Tch
(C.129X1-Il4ratm3.1Tch) 		increased susceptibility to type I hypersensitivity reaction J:160806
Il6sttm1Ern/Il6sttm1Ern
(involves: 129S1/Sv) 		increased susceptibility to endotoxin shock J:168781
Il10tm1.1Roer/Il10tm1.1Roer
(involves: 129P2/OlaHsd) 		increased susceptibility to endotoxin shock J:151551
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to type IV hypersensitivity reaction J:51636
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd) 		increased susceptibility to endotoxin shock J:117122, J:118833
Il10tm2Roer/Il10tm2Roer
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to endotoxin shock J:117122
Il10tm2Roer/Il10tm2Roer
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2) 		increased susceptibility to endotoxin shock J:117122
Il13tm2Anjm/Il13tm2Anjm
(C.129P2(B6)-Il13tm2Anjm) 		increased susceptibility to type I hypersensitivity reaction J:123772
Il20rbtm1Uwe/Il20rbtm1Uwe
(C.129P2-Il20rbtm1Uwe) 		increased susceptibility to type IV hypersensitivity reaction J:143497
Il22tm1Flv/Il22+
(B6.Cg-Il22tm1Flv) 		increased susceptibility to endotoxin shock J:126103
Il22tm1Flv/Il22tm1Flv
(B6.Cg-Il22tm1Flv) 		increased susceptibility to endotoxin shock J:126103
Il25tm1.1Cdon/Il25tm1.1Cdon
(involves: 129S6/SvEvTac) 		increased susceptibility to type I hypersensitivity reaction J:158594
Il27tm1Cua/Il27tm1Cua
(C57BL/6-Il27tm1Cua) 		increased susceptibility to type IV hypersensitivity reaction J:147706
Irak3tm1Flv/Irak3tm1Flv
(involves: 129S1/Sv * C57BL/6) 		increased susceptibility to endotoxin shock J:78189
Jundtm1Mya/Jundtm1Mya
(either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6)) 		increased susceptibility to endotoxin shock J:65879
Kcnj8mydy/Kcnj8mydy
(involves: C57BL/6J) 		increased susceptibility to endotoxin shock J:126658
Kcnj8sos/Kcnj8sos
(C57BL/6J-Kcnj8sos) 		increased susceptibility to endotoxin shock J:149353
Lacc1em3Arkr/Lacc1em3Arkr
(C57BL/6NTac-Lacc1em3Arkr) 		increased susceptibility to endotoxin shock J:244365
Lacc1em4Arkr/Lacc1em4Arkr
(C57BL/6NTac-Lacc1em4Arkr) 		increased susceptibility to endotoxin shock J:244365
Lacc1tm1a(KOMP)Wtsi/Lacc1tm1a(KOMP)Wtsi
(involves: C57BL/6N * C57BL/6NTac) 		increased susceptibility to endotoxin shock J:244365
Lat2tm1Wz/Lat2tm1Wz
(Not Specified) 		increased susceptibility to endotoxin shock J:181866
Lat2tm3.1Wz/Lat2tm3.1Wz
(B6.Cg-Lat2tm3.1Wz) 		increased susceptibility to endotoxin shock J:181866
Lepob/Lepob
(B6.Cg-Lepob/OlaHsd) 		increased susceptibility to endotoxin shock J:124815
Leprdb/Leprdb
(BKS.Cg-Dock7m +/+ Leprdb/OlaHsd) 		increased susceptibility to endotoxin shock J:124815
Lgals2tm1.1Cfg/Lgals2tm1.1Cfg
(involves: C57BL/6) 		increased susceptibility to type IV hypersensitivity reaction J:217719
Lgals3bptm1Megt/Lgals3bptm1Megt
(involves: 129P2/OlaHsd * C57BL/Ka) 		increased susceptibility to endotoxin shock J:94936
Liftm1Stw/Liftm1Stw
(involves: 129S1/Sv * C57BL/6) 		increased acute inflammation J:119777
Liftm1Stw/Liftm1Stw
(involves: 129S1/Sv * BALB/c) 		increased susceptibility to endotoxin shock J:136940
Lilrb4atm1Hrk/Lilrb4atm1Hrk
(involves: 129/Sv * BALB/c) 		increased susceptibility to type I hypersensitivity reaction J:70491
Lpar2tm1Dgen/Lpar2tm1Dgen
(B6.Cg-Lpar2tm1Dgen) 		increased susceptibility to type I hypersensitivity reaction J:184061
Lyz2tm1(cre)Ifo/Lyz2+
Pikfyvetm1b(EUCOMM)Hmgu/Pikfyvetm1b(EUCOMM)Hmgu
(involves: 129P2/OlaHsd * C57BL/6N) 		increased susceptibility to type I hypersensitivity reaction J:244776
Map3k7tm1.1Gkl/Map3k7tm1.1Gkl
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to endotoxin shock J:211916
Marchf2em1Cnu/Marchf2em1Cnu
(C57BL/6-Marchf2em1Cnu) 		increased susceptibility to endotoxin shock J:297482
Mefvtm1Chae/Mefvtm1Chae
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6)) 		increased susceptibility to endotoxin shock J:82763
Mertktm1Gkm/Mertktm1Gkm
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		increased susceptibility to endotoxin shock J:53423
Metrnltm1d(KOMP)Wtsi/Metrnltm1d(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N) 		increased susceptibility to endotoxin shock J:268270
Mfsd2btm1a(KOMP)Wtsi/Mfsd2btm1a(KOMP)Wtsi
(C57BL/6-Mfsd2btm1a(KOMP)Wtsi) 		increased susceptibility to type I hypersensitivity reaction J:250123
Milr1tm1Shib/Milr1tm1Shib
(involves: C57BL/6N) 		increased susceptibility to type I hypersensitivity reaction J:161854
Mir21atm1.1Mer/Mir21atm1.1Mer
(involves: 129S1/Sv * C57BL/6 * FVB/N) 		increased susceptibility to type I hypersensitivity reaction J:179235
Mir21atm1.1Mer/Mir21atm1.1Mer
(B6.129S1-Mir21atm1.1Mer) 		increased susceptibility to type IV hypersensitivity reaction J:179235
Mir146tm1.1Bal/Mir146tm1.1Bal
(involves: C57BL/6 * FVB/N) 		increased susceptibility to endotoxin shock J:173671
Mir146tm2.1Bal/Mir146tm2.1Bal
(involves: 129S1/Sv * C57BL/6 * FVB/N) 		increased acute inflammation J:173671
increased susceptibility to endotoxin shock J:173671
Mir149em1Ydw/Mir149em1Ydw
(C57BL/6J-Mir149em1Ydw) 		increased susceptibility to endotoxin shock J:294318
Mir223tm1Fcam/Mir223tm1Fcam
(involves: 129S4/SvJae * C57BL/6) 		increased acute inflammation J:140009
Mmetm1Cge/Mmetm1Cge
(B6.129S4-Mmetm1Cge) 		increased susceptibility to type I hypersensitivity reaction J:66854
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129/Sv * 129S6/SvEvTac) 		increased susceptibility to type IV hypersensitivity reaction J:55723
Mst1rtm1.1Sew/Mst1rtm1.1Sew
(involves: 129/Ola * CD-1 * NIH Black Swiss) 		increased acute inflammation J:75503
increased susceptibility to endotoxin shock J:75503
Nba5NZB/Nba5NZB
(C57BL/6-Nba5 Yaa) 		increased susceptibility to type III hypersensitivity reaction J:95829
Nba10NZB/?
(involves: C57BL/6 * NZB * SB/Le) 		increased susceptibility to type III hypersensitivity reaction J:95829
Nba10NZB/Nba10NZB
X/Yaa
(C57BL/6-Nba2 Yaa) 		increased susceptibility to type III hypersensitivity reaction J:95829
Ncf1tm1Shl/Ncf1tm1Shl
(involves: 129S2/SvPas * C57BL/6J) 		increased acute inflammation J:28267
Ncoa3tm1Jxu/Ncoa3tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6) 		increased susceptibility to endotoxin shock J:120086
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * CD-1) 		increased acute inflammation J:122813
Nfkbidtm1Ktak/Nfkbidtm1Ktak
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to endotoxin shock J:113334
Nlrc3tm1Bhk/Nlrc3tm1Bhk
(B6.129S6-Nlrc3tm1Bhk) 		increased susceptibility to endotoxin shock J:187586
Nlrp3tm1Wstr/Nlrp3+
(involves: C57BL/6) 		increased susceptibility to type IV hypersensitivity reaction J:150053
Nlrx1tm1Jpyt/Nlrx1tm1Jpyt
(involves: C57BL/6 * C57BL/6J) 		increased susceptibility to endotoxin shock J:173995
Nr3c1tm2Ljm/Nr3c1tm2Ljm
Tg(Lck-cre)548Jxm/?
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		increased susceptibility to endotoxin shock J:97484
Nr4a1tm1Jmi/Nr4a1tm1Jmi
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to endotoxin shock J:239509
Ntan1tm1Avar/Ntan1tm1Avar
(involves: 129) 		increased acute inflammation J:62140
Nudt21tm1.1Ejwpj/Nudt21tm1.1Ejwpj
Tg(Col1a1-cre/ERT2)1Crm/0
(involves: C57BL/6J * CBA/J) 		increased acute inflammation J:283035
Orai2tm1.1Itl/Orai2tm1.1Itl
Tg(Cma1-cre)#Roer/0
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N) 		increased susceptibility to type I hypersensitivity reaction J:278536
Otcspf-ash/Y
(B6EiC3Sn a/A-Otcspf-ash/J) 		increased susceptibility to endotoxin shock J:108979
Otud1em2Gpt/Otud1em2Gpt
(C57BL/6-Otud1em2Gpt) 		increased susceptibility to endotoxin shock J:287309
Pargtm1Zqw/Pargtm1Zqw
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to endotoxin shock J:92244
Pcsk1tm1Dfs/Pcsk1tm1Dfs
(involves: 129 * C57BL/6J) 		increased susceptibility to endotoxin shock J:184882
Pias1tm1Kes/Pias1tm1Kes
(involves: 129S/Sv * C57BL/6) 		increased susceptibility to endotoxin shock J:92167
Pilratm1Osb/Pilratm1Osb
(B6.129-Pilratm1Osb) 		increased susceptibility to endotoxin shock J:191085
Pip5k1btm1Tssk/Pip5k1btm1Tssk
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to type I hypersensitivity reaction J:97991
Pla2g2dtm1.1Mhg/Pla2g2dtm1.1Mhg
(B6NCrSlc.Cg-Pla2g2dtm1.1Mhg) 		increased susceptibility to type IV hypersensitivity reaction J:201008
Pla2g4atm1Tksh/Pla2g4atm1Tksh
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to type I hypersensitivity reaction J:39254
Plcd1tm1.1Kfu/Plcd1tm1.1Kfu
Tg(KRT14-cre)1Amc/0
(involves: C57BL/6 * C57BL/6JJcl * CBA) 		increased susceptibility to type IV hypersensitivity reaction J:205633
Ppiatm1Lubn/Ppiatm1Lubn
(129S6.129P2-Ppiatm1Lubn) 		increased susceptibility to type I hypersensitivity reaction J:93591
Ppm1atm1.2Lavi/Ppm1atm1.2Lavi
(B.129(Cg)-Ppm1atm1.2Lavi) 		increased acute inflammation J:216372
Prkcdtm1Kin/Prkcdtm1Kin
(involves: 129P2/OlaHsd * C57BL/6) 		increased acute inflammation J:76135
Procrtm1.1Pcl/Procrtm1.1Pcl
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to endotoxin shock J:225914
Ptafrtm1Tksh/Ptafrtm1Tksh
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to type I hypersensitivity reaction J:88505
Ptgdr2tm1Tasa/Ptgdr2tm1Tasa
(B6.129-Ptgdr2tm1Tasa) 		increased susceptibility to type I hypersensitivity reaction J:197334
Ptger3tm1Sna/Ptger3tm1Sna
(B6.129P2-Ptger3tm1Sna/Sna) 		increased susceptibility to type I hypersensitivity reaction J:197334
Ptges2tm1Kymm/Ptges2tm1Kymm
(B6.Cg-Ptges2tm1Kymm) 		increased susceptibility to type I hypersensitivity reaction J:197334
Ptgestm1Aki/Ptgestm1Aki
(B6.129P2-Ptgestm1Aki) 		increased susceptibility to type I hypersensitivity reaction J:197334
Ptgs1tm1Unc/Ptgs1tm1Unc
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to endotoxin shock J:75611
Ptgs2tm1.1Wls/Ptgs2tm1.1Wls
(B6.129-Ptgs2tm1.1Wls) 		increased susceptibility to endotoxin shock J:156331
Ptpn11tm1Gsf/Ptpn11tm1Gsf
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		increased acute inflammation J:172422
Rab26em1Guwa/Rab26em1Guwa
(Not Specified) 		increased susceptibility to endotoxin shock J:306921
Rab44em1Rbrc/Rab44em1Rbrc
(Not Specified) 		increased susceptibility to type I hypersensitivity reaction J:304506
Rcan1tm1Fmc/Rcan1tm1Fmc
(involves: 129S4/SvJae) 		increased susceptibility to endotoxin shock J:152536
Relatm1Mpa/Relatm1Mpa
Tg(Alb1-cre)7Gsc/0
(involves: FVB/N) 		increased susceptibility to endotoxin shock J:137861
Rgs3tm1Ndul/Rgs3tm1Ndul
(B6.129-Rgs3tm1Ndul) 		increased susceptibility to type I hypersensitivity reaction J:210195
Rgs13tm1Drue/Rgs13tm1Drue
(B6.129S-Rgs13tm1Drue) 		increased susceptibility to type I hypersensitivity reaction J:130209
Rhbdd1tm1.1Mfm/Rhbdd1tm1.1Mfm
(involves: 129S/SvEv * C57BL/6J) 		increased susceptibility to endotoxin shock J:346394
Rps6ka4tm1Jsca/Rps6ka4tm1Jsca
Rps6ka5tm1Jsca/Rps6ka5tm1Jsca
(B6.Cg-Rps6ka5tm1Jsca Rps6ka4tm1Jsca) 		increased susceptibility to endotoxin shock J:139576
Sbsnem1Ham/Sbsnem1Ham
(C57BL/6N-Sbsnem1Ham) 		increased susceptibility to type IV hypersensitivity reaction J:296400
Sectm1aem1Gcfa/Sectm1aem1Gcfa
(C57BL/6-Sectm1aem1Gcfa) 		increased susceptibility to endotoxin shock J:317204
Serpina1em#Chmu/Serpina1em#Chmu
(involves: C57BL/6J) 		increased susceptibility to endotoxin shock J:259615
Serpina6tm1Tew/Serpina6tm1Tew
(involves: 129/SvEmcTer * C57BL/6N) 		increased susceptibility to endotoxin shock J:112974
Serpine1tm1Mlg/Serpine1tm1Mlg
(involves: 129S2/SvPas * C57BL/6) 		increased acute inflammation J:133227
Sgp5NZB/?
(involves: C57BL/6 * NZB * SB/Le) 		increased susceptibility to type III hypersensitivity reaction J:95829
Sigirrtm1Lix/Sigirrtm1Lix
(involves: 129S6/SvEvTac * BALB/c) 		increased susceptibility to endotoxin shock J:85151
Slc2a6em1Kusu/Slc2a6em1Kusu
(involves: C57BL/6JCrlj) 		increased susceptibility to endotoxin shock J:270487
Slc37a2tm1Dgen/Slc37a2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to endotoxin shock J:311521
Slpitm1Nkw/Slpitm1Nkw
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to endotoxin shock J:82214
Smpdl3btm1a(EUCOMM)Wtsi/Smpdl3btm1a(EUCOMM)Wtsi
(C57BL/6-Smpdl3btm1a(EUCOMM)Wtsi) 		increased susceptibility to endotoxin shock J:224870
Srxn1tm1Mtol/Srxn1tm1Mtol
(either: B6.129S2-Srxn1tm1Mtol or (involves: 129S2/SvPasCrl * C57BL/6)) 		increased susceptibility to endotoxin shock J:199277
Sstr4tm1Szo/Sstr4tm1Szo
(B6.129P2-Sstr4tm1Szo) 		increased susceptibility to type IV hypersensitivity reaction J:152015
Stard7tm1a(EUCOMM)Wtsi/Stard7+
(involves: C57BL/6N) 		increased susceptibility to type I hypersensitivity reaction J:242746
Stat3tm1Desi/Stat3tm1Desi
(involves: 129X1/SvJ * C57BL/6) 		increased susceptibility to endotoxin shock J:77307
Stat3tm1Flv/Stat3tm1Flv
Tg(Tek-cre)1Xyfu/0
(involves: C57BL/6) 		increased susceptibility to endotoxin shock J:86655
Stat3tm1Xyfu/Stat3+
Tg(Myh6-cre)2182Mds/0
(involves: 129S1/Sv * FVB/N) 		increased susceptibility to endotoxin shock J:86400
Stat3tm1Xyfu/Stat3tm1.1Xyfu
Tg(Myh6-cre)2182Mds/0
(involves: 129S1/Sv * FVB/N) 		increased susceptibility to endotoxin shock J:86400
Stip1tm1.2Mamp/Stip1tm1.2Mamp
(involves: C57BL/6) 		increased acute inflammation J:201097
Tbk1tm1.1Lex/Tbk1tm1.1Lex
(involves: 129S4/SvJae * 129S5/SvEvBrd) 		increased susceptibility to endotoxin shock J:166476
Tbxa2rtm1Sna/Tbxa2rtm1Sna
(B6.Cg-Tbxa2rtm1Sna) 		increased susceptibility to type I hypersensitivity reaction J:197334
Tcrdtm1Mom/Tcrdtm1Mom
(FVB.129P2-Tcrdtm1Mom) 		increased susceptibility to type IV hypersensitivity reaction J:75915
Tg(Actb-Tnfsf4)1Nish/0
(B6.D2-Tg(Actb-Tnfsf4)1Nish) 		increased susceptibility to type IV hypersensitivity reaction J:80214
Tg(CAG-PLA2G3)#aMurm/0
(Not Specified) 		increased susceptibility to type I hypersensitivity reaction J:197334
Tg(CAG-Ptafr)1Tksh/0
(B6;D2-Tg(CAG-Ptafr)1Tksh/TkshRbrc) 		increased susceptibility to endotoxin shock J:38639
Tg(Cd4-Il17rb)#Cdon/?
(involves: C57BL/6) 		increased susceptibility to type I hypersensitivity reaction J:158594
Tg(CD207-Dta)312Dhka/?
(FVB-Tg(CD207-Dta)312Dhka) 		increased susceptibility to type IV hypersensitivity reaction J:113309
Tg(FCGR2A)11Mkz/0
Tg(PF4)#Zcy/0
(involves: C57BL/6 * SJL) 		increased acute inflammation J:72220
Tg(Foxp3-HBEGF/EGFP)23.2Spar/0
(involves: C57BL/6NCrl) 		increased susceptibility to type IV hypersensitivity reaction J:125295
Tg(Lck-Tnfsf4)1Nish/0
(B6.Cg-Tg(Lck-Tnfsf4)1Nish) 		increased susceptibility to type IV hypersensitivity reaction J:80214
Tg(Lck-VIPR2)1Ejg/0
(C57BL/6-Tg(Lck-VIPR2)1Ejg) 		increased susceptibility to type I hypersensitivity reaction J:127974
Tg(Pim1-Il9)5Jcrd/0
(involves: BALB/c * FVB/N) 		increased susceptibility to type I hypersensitivity reaction J:100568
Tg(Pim1-Il9)5Jcrd/0
(involves: FVB/N) 		increased susceptibility to type I hypersensitivity reaction J:100568
Tg(Sirt1)ASrn/?
(involves: C57BL/6 * CBA) 		increased susceptibility to endotoxin shock J:137868
Tg(Stat3*)9199Alau/0
(involves: C57BL/6) 		increased susceptibility to endotoxin shock J:210877
Thbdtm1Wlr/Thbdtm1Wlr
(B6.129S2-Thbdtm1Wlr) 		increased susceptibility to endotoxin shock J:111502
Thbdtm2.1Emc/Thbdtm2.1Emc
(involves: 129/Sv * BALB/c * C57BL/6) 		increased susceptibility to endotoxin shock J:118000
Tia1tm1Andp/Tia1tm1Andp
(C.129S2-Tia1tm1Andp) 		increased susceptibility to endotoxin shock J:88770
Tnftm1Gkl/Tnftm2Gkl
(involves: 129S/SvEv * C57BL/6) 		increased susceptibility to endotoxin shock J:54056
Tnfaip8l2tm1Yhcn/Tnfaip8l2tm1Yhcn
(129S6/SvEvTac-Tnfaip8l2tm1Yhcn) 		increased susceptibility to endotoxin shock J:139785
Tnfrsf1atm1Blt/Tnfrsf1atm1Blt
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to type I hypersensitivity reaction J:92307
Tnfrsf1atm1Rsie/Tnfrsf1a+
(B6.Cg-Tnfrsf1atm1Rsie) 		increased susceptibility to endotoxin shock J:160543
Tnfrsf1atm2.1Rsie/Tnfrsf1a+
(B6.Cg-Tnfrsf1atm2.1Rsie) 		increased susceptibility to endotoxin shock J:160543
Tnfrsf1atm2.1Rsie/Tnfrsf1a+
(involves: 129S6/SvEvTac) 		increased susceptibility to endotoxin shock J:160543
Trafd1tm1Ayos/Trafd1tm1Ayos
(involves: 129 * C57BL/6J) 		increased susceptibility to endotoxin shock J:144594
Trem2em2Bwef/Trem2em2Bwef
(involves: C57BL/6J * DBA/2J * FVB/N) 		increased susceptibility to endotoxin shock J:242126
Treml1tm1Mcvic/Treml1tm1Mcvic
(C57BL/6-Treml1tm1Mcvic) 		increased susceptibility to endotoxin shock J:150578
Trim8tm1Hbsh/Trim8tm1Hbsh
(involves: 129S6/SvEvTac) 		increased susceptibility to endotoxin shock J:251270
Trpm4tm1.1Mfre/Trpm4tm1.1Mfre
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ) 		increased susceptibility to type I hypersensitivity reaction J:118679
Trpm7tm1Agry/Trpm7+
(involves: 129) 		increased susceptibility to type IV hypersensitivity reaction J:205665
Tsc22d3tm1.2Efmd/Y
(Not Specified) 		increased susceptibility to type IV hypersensitivity reaction J:201728
Ttc39aos1tm1Kaf/Ttc39aos1tm1Kaf
(C57BL/6-Ttc39aos1tm1Kaf) 		increased susceptibility to endotoxin shock J:234649
U90926em1Dnkv/U90926em1Dnkv
(C57BL6/J-U90926em1Dnkv) 		increased susceptibility to endotoxin shock J:340649
Usp18ity9/Usp18ity9
(involves: 129S1/SvImJ * C57BL/6) 		increased susceptibility to endotoxin shock J:163843
Vipr2tm1Ajh/Vipr2tm1Ajh
(B6.129P2-Vipr2tm1Ajh) 		increased susceptibility to type IV hypersensitivity reaction J:72933
Vwftm1.1Geno/Vwf+
(involves: C57BL/6) 		increased acute inflammation J:250145
Vwftm1.1Geno/Vwftm1.1Geno
(involves: C57BL/6) 		increased acute inflammation J:250145
Zfp36tm4.1Pjb/Zfp36tm4.1Pjb
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N) 		increased susceptibility to endotoxin shock J:188677
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
04/16/2024
MGI 6.23 		The Jackson Laboratory